A detailed history of California Public Employees Retirement System transactions in Biogen Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 395,071 shares of BIIB stock, worth $58.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
395,071
Previous 396,065 0.25%
Holding current value
$58.9 Million
Previous $91.8 Million 16.59%
% of portfolio
0.05%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $187,935 - $235,379
-994 Reduced 0.25%
395,071 $76.6 Million
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $1.59 Million - $1.98 Million
-8,354 Reduced 2.07%
396,065 $91.8 Million
Q1 2024

Apr 30, 2024

BUY
$212.02 - $267.71 $8.74 Million - $11 Million
41,210 Added 11.35%
404,419 $87.2 Million
Q4 2023

Feb 01, 2024

BUY
$222.59 - $267.94 $18.3 Million - $22 Million
82,046 Added 29.18%
363,209 $94 Million
Q3 2023

Nov 02, 2023

BUY
$253.3 - $285.89 $1.65 Million - $1.87 Million
6,532 Added 2.38%
281,163 $72.3 Million
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $9.63 Million - $11.1 Million
-34,986 Reduced 11.3%
274,631 $78.2 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $16 Million - $18.2 Million
-62,275 Reduced 16.75%
309,617 $86.1 Million
Q4 2022

Feb 08, 2023

SELL
$252.44 - $306.72 $3.56 Million - $4.33 Million
-14,101 Reduced 3.65%
371,892 $103 Million
Q3 2022

Nov 09, 2022

BUY
$194.69 - $268.46 $2.74 Million - $3.78 Million
14,096 Added 3.79%
385,993 $103 Million
Q2 2022

Aug 10, 2022

SELL
$187.54 - $223.02 $10.2 Million - $12.1 Million
-54,459 Reduced 12.77%
371,897 $75.8 Million
Q1 2022

May 04, 2022

SELL
$193.77 - $244.14 $4.73 Million - $5.95 Million
-24,385 Reduced 5.41%
426,356 $89.8 Million
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $3.92 Million - $5.04 Million
-17,527 Reduced 3.74%
450,741 $108 Million
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $1.48 Million - $1.93 Million
-5,238 Reduced 1.11%
468,268 $133 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $26.1 Million - $41.8 Million
100,803 Added 27.05%
473,506 $164 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $3.65 Million - $4.27 Million
-15,019 Reduced 3.87%
372,703 $104 Million
Q4 2020

Feb 02, 2021

BUY
$236.26 - $355.63 $1.98 Million - $2.98 Million
8,375 Added 2.21%
387,722 $94.9 Million
Q3 2020

Nov 05, 2020

BUY
$264.77 - $305.71 $261,327 - $301,735
987 Added 0.26%
379,347 $108 Million
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $6.19 Million - $8.2 Million
-23,929 Reduced 5.95%
378,360 $101 Million
Q1 2020

May 12, 2020

SELL
$268.85 - $341.04 $14 Million - $17.7 Million
-51,914 Reduced 11.43%
402,289 $127 Million
Q4 2019

Jan 27, 2020

SELL
$220.06 - $304.07 $9.09 Million - $12.6 Million
-41,328 Reduced 8.34%
454,203 $135 Million
Q3 2019

Oct 31, 2019

BUY
$217.44 - $243.88 $8.51 Million - $9.54 Million
39,137 Added 8.58%
495,531 $115 Million
Q2 2019

Aug 15, 2019

SELL
$219.29 - $241.72 $5.54 Million - $6.11 Million
-25,279 Reduced 5.25%
456,394 $107 Million
Q1 2019

May 03, 2019

BUY
$216.71 - $338.96 $378,158 - $591,485
1,745 Added 0.36%
481,673 $114 Million
Q4 2018

Feb 08, 2019

SELL
$278.5 - $352.75 $8.35 Million - $10.6 Million
-29,969 Reduced 5.88%
479,928 $144 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $11.4 Million - $14.9 Million
-38,778 Reduced 7.07%
509,897 $180 Million
Q2 2018

Aug 15, 2018

BUY
$257.52 - $306.91 $139,060 - $165,731
540 Added 0.1%
548,675 $159 Million
Q1 2018

May 11, 2018

BUY
$260.13 - $367.91 $4.14 Million - $5.85 Million
15,899 Added 2.99%
548,135 $150 Million
Q4 2017

Feb 06, 2018

BUY
$307.64 - $344.58 $8.83 Million - $9.9 Million
28,718 Added 5.7%
532,236 $170 Million
Q3 2017

Nov 15, 2017

BUY
$281.15 - $329.69 $142 Million - $166 Million
503,518
503,518 $158 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.